Latest Research Reports

Belimumab: The frontrunner in Lupus clinical trials

Belimumab: The frontrunner in Lupus clinical trials

Risk of sepsis is higher in an older population

Risk of sepsis is higher in an older population

The US and the UK see a high percentage of CDT+ CDI cases

The US and the UK see a high percentage of CDT+ CDI cases

Emerging rivals in CAR-T cell therapies

Emerging rivals in CAR-T cell therapies

AEDs targeting rare epilepsy syndromes set to shoot to top of the market

AEDs targeting rare epilepsy syndromes set to shoot to top of the market

Novartis leads Japanese clinical trials

Novartis leads Japanese clinical trials

Top sponsors for 2007-2016 stem cell therapy clinical trials

Top sponsors for 2007-2016 stem cell therapy clinical trials

Nanobodies leading the way for biotech R&D deal

Nanobodies leading the way for biotech R&D deal

Early detection of invasive breast cancer substandard in urban China

Early detection of invasive breast cancer substandard in urban China

Healthcare-related CDIs rivaled by community cases

Healthcare-related CDIs rivaled by community cases

Declining trend in Japanese clinical trials

Declining trend in Japanese clinical trials

Will Orencia be able to compete in an already crowded market?

Will Orencia be able to compete in an already crowded market?

Non-industry trials were more frequent than industry trials in 2016

Non-industry trials were more frequent than industry trials in 2016

Analyst forecasted growth of battling blockbusters, Keytruda and Opdivo

Analyst forecasted growth of battling blockbusters, Keytruda and Opdivo

AML therapeutics market expected to diversify by 2026

AML therapeutics market expected to diversify by 2026

Which class of drugs is set to have the biggest impact on the cancer market?

Which class of drugs is set to have the biggest impact on the cancer market?

Novartis, Pfizer, Amgen, and Merck: key players in the autoimmune biosimilars space

Novartis, Pfizer, Amgen, and Merck: key players in the autoimmune biosimilars space

EMA set to approve plethora of oncology drugs

EMA set to approve plethora of oncology drugs

Top indications and therapy areas for 2012-2016 clinical trials in Israel

Top indications and therapy areas for 2012-2016 clinical trials in Israel

The global burden of rheumatoid arthritis will increase

The global burden of rheumatoid arthritis will increase

Orphan cancer drugs take up 37% of market share

Orphan cancer drugs take up 37% of market share